FindTrial
Sign In

To study the effect of test product in reducing wrinkles and making facial skin smooth and glowing in women.

A monocentric, single group, 12 week trial to evaluate the benefits of a serum in reducing expression lines, improving texture and radiance of facial skin in women and its in use tolerance. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090493
Enrollment
34
Registered
2025-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: FirmX serum: Face will be washed and dabbed dry with towel. A thin layer of serum (approximately 0.5 ml) will be applied on face, by gentle massaging, twice daily-morning and night for

Sponsors

Earthy Biome
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Voluntary women from 30 years to 65 years of age. 2. Volunteers with expression lines (nasolabial folds, forehead wrinkles, wrinkles &fine lines in crow s feet area, marionette lines, undereye wrinkles & Fine lines). 3. Having apparently healthy skin on test area. 4. Willingness to discontinue the use of other cosmetic products on face during the course of the study. 5. Willing to avoid unusual sun exposure as far as possible for the entire study duration. 6. Accepting not to use products with the same end benefit during the entire study duration. 7. Cooperating, informed of the need and duration of the examinations, and ready to comply with protocol procedures. 8. Ready to provide consent, having been informed orally and in writing of all information concerning the study procedures and study objectives.

Exclusion criteria

Exclusion criteria: 1. Female who is pregnant by UPT or lactating. 2. Any cutaneous conditions on test site (scars, moles, papules etc). 3. Participants hypersensitive to any of the components of the test product. 4. Participants having any hard damage to skin (e.g., excessive sunburn or suntan). 5. Participants on any systemic medical treatment which may interfere with the performance of the study treatment (presently or in the past 1 month). 6. Participant in an exclusion period or participating in any clinical trial within 30 days prior to screening.

Design outcomes

Primary

MeasureTime frame
1. 3D Imaging for expression lines (nasolabial folds, forehead wrinkles, wrinkles &fine lines in crow s feet area, marionette lines, undereye wrinkles and Fine lines) 2. 3D Imaging for skin texture (skin smoothness). 3. Skin radiance using Glossmeter. 4. Self-assessment for product efficacy.Timepoint: Day 0, Day7, Day 90—

Secondary

MeasureTime frame
1. Clinical evaluation for in-use skin tolerance. 2. Self-assessment questionnaire for in use tolerance.Timepoint: Day7, Day 90—

Countries

India

Contacts

Public ContactMs Preetha Paul

Clinical Aesthetics and Investigative Management Service Pvt. Ltd. (C.L.A.I.M.S.PVT.LTD.

preetha@claimsclinical.com66758851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026